Robert Izquierdo, The Motley Fool
Sun, May 17, 2026 astatine 10:33 AM CDT 4 min read
Lynne N. Ward, Director astatine Merit Medical Systems (NASDAQ:MMSI), reported an open-market merchantability of 5,000 shares for a full of astir $313,000, according to the SEC Form 4 filing.
Transaction summary
| Shares sold (direct) | 5,000 |
| Transaction value | ~$313,000 |
| Post-transaction shares (direct) | 7,809 |
| Post-transaction worth (direct ownership) | ~$489,000 |
Transaction and post-transaction worth based connected SEC Form 4 weighted mean acquisition terms ($62.61).
Key questions
-
How did the transaction impact Lynne Ward's ownership successful Merit Medical Systems?
The merchantability reduced Ward's nonstop holdings by 39%, from 12,809 shares to 7,809 shares, with nary remaining indirect oregon derivative securities reported. -
Were immoderate different forms of disposition, specified arsenic gifts oregon withholdings, progressive successful this filing?
No; the filing strictly reflects a nonstop open-market sale, with nary gifts oregon shares withheld for taxes oregon administrative purposes. -
What does the transaction size bespeak astir Ward's trading signifier and remaining capacity?
The 5,000-share merchantability is the lone open-market merchantability successful the past 12 months and reflects a larger proportionality of Ward's shrinking disposable holdings, accordant with the ongoing simplification successful presumption size. -
What continuing involvement does Ward person successful Merit Medical Systems pursuing this sale?
Despite the reduction, Ward retains 7,809 shares of Common Stock (direct), maintaining a continuing ownership position.
Company overview
| Revenue (TTM) | $1.54 billion |
| Net income (TTM) | $139.34 million |
| Employees | 7,400 |
| 1-year terms change | (36.06%) |
* 1-year terms alteration calculated utilizing May 7, 2026 arsenic the notation date.
Company snapshot
-
Merit Medical Systems designs, manufactures, and markets single-use aesculapian products for interventional, diagnostic, and therapeutic procedures, with a absorption connected cardiology, radiology, oncology, captious care, and endoscopy.
-
It generates gross done the nonstop merchantability and organisation of proprietary aesculapian devices and customized procedural solutions to healthcare providers and OEM partners.
-
The institution serves hospitals, physicians, technicians, and nurses successful the United States and planetary markets done a operation of nonstop income and distributor relationships.
Merit Medical Systems, Inc. is simply a starring supplier of single-use aesculapian devices, operating astatine standard with implicit 7,400 employees and a planetary footprint. The company's strategy centers connected innovation successful minimally invasive procedures and procedural efficiency, supporting its competitory presumption successful the aesculapian instruments and supplies sector.

1 hour ago
4





English (CA) ·
English (US) ·
Spanish (MX) ·